What you'll learn in this expert session
Continuous glucose monitoring (CGM) is now being recommended as the standard of care for any patient on intensive insulin therapy, not just those with type 1 diabetes. In this talk, A/Prof Gary Kilov AM will present the evidence that supports current guidelines for CGM to be used in patients with type 2 diabetes who are on insulin. He will also address the logistics of commencing CGM in this cohort - including the when, how, for how long and choice of device. An important update in a rapidly evolving area of medicine.
About the Expert
A/Prof Gary Kilov AM
A/Prof Gary Kilov AM is a founding member of the RACGP (Royal Australian College of GPs) Diabetes Specific Interest Group and a co-founder of the Primary Care Diabetes Society of Australia and past Editor in Chief of the Society’s journal, Diabetes & Primary Care Australia. He is a contributor to the current RACGP diabetes handbook (2016-2024) and a member of several National Diabetes Supply Scheme Expert Reference Groups. He has been afforded the honorary title of Clinical Associate Professor in the Department of General Practice and Primary Care at Melbourne University. A/Prof Kilov has established a multidisciplinary, diabetes-focused general practice in Launceston, Tasmania. He shares his time between Launceston treating the full spectrum of patients with diabetes and obesity-related conditions and providing peer-to-peer and medical undergraduate education on diabetes and related conditions. He has presented papers and conducted numerous educational sessions at national and international seminars and conferences, and he has been published in peer-reviewed journals on topics related to diabetes, obesity, and respiratory medicine. A/Prof Kilov brings a personal perspective to his work, having lived with type one diabetes and lifelong coeliac disease.
